Pfizer (PFE) Tops Q3 EPS by 29c, Raises FY Guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $24.32 --0%
EPS Growth %: -12.8%
Financial Fact:
Net income before allocation to noncontrolling interests: 1.32B
Today's EPS Names:
CRMT, PKE, More
EPS Growth %: -12.8%
Financial Fact:
Net income before allocation to noncontrolling interests: 1.32B
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q3 EPS of $1.37, $0.29 better than the analyst estimate of $1.08. Revenue for the quarter came in at $24.1 billion versus the consensus estimate of $22.68 billion.
GUIDANCE:
Pfizer sees 2021 EPS of $4.13-$4.18 (previously $3.95 to $4.05). Pfizer sees 2021 revenue of $81-82 billion (previously $78.0 to $80.0 billion).
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Downgrades Pfizer (PFE) to Hold
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
- Canaccord Reiterates Buy Rating on Seer Inc. (SEER)
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
